Results 161 to 170 of about 31,195 (193)
Some of the next articles are maybe not open access.
Drugs, 2008
Tigecycline is a first-in-class glycylcycline, broad-spectrum, intravenous antibacterial developed to overcome the two major mechanisms of tetracycline resistance (ribosomal protection and efflux). The drug has been in use since 2005 for complicated intra-abdominal infections, and complicated skin and soft tissue structure infections, but is currently ...
Kate, McKeage, Gillian M, Keating
openaire +2 more sources
Tigecycline is a first-in-class glycylcycline, broad-spectrum, intravenous antibacterial developed to overcome the two major mechanisms of tetracycline resistance (ribosomal protection and efflux). The drug has been in use since 2005 for complicated intra-abdominal infections, and complicated skin and soft tissue structure infections, but is currently ...
Kate, McKeage, Gillian M, Keating
openaire +2 more sources
European Journal of Clinical Microbiology and Infectious Diseases, 2022
Farajollah Maleki +2 more
exaly
Farajollah Maleki +2 more
exaly

